Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1999
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064030A1 Methods and compositions for treating arthritis
12/16/1999WO1999064022A1 Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system
12/16/1999WO1999064021A1 hCEPR RECEPTOR
12/16/1999WO1999064016A1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
12/16/1999WO1999064013A1 Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase
12/16/1999WO1999064002A1 Spiropiperidine derivatives as melanocortin receptor agonists
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063976A2 Liver-selective glucocorticoid antagonist for treating diabetes
12/16/1999WO1999063975A2 A method for stimulating the immune system
12/16/1999WO1999063964A1 Method for preparing fibrillin from cnidaria, and resulting compositions useful in cosmetics
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999WO1999063938A2 Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs
12/16/1999WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063931A2 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999WO1999063828A1 Broad specificity dna damage endonuclease
12/16/1999WO1999057251A3 Thrombolytic agents derived from streptokinase
12/16/1999WO1999056700A3 Avian polyomavirus vaccines in psittacine birds
12/16/1999WO1999055856A3 Nucleic acid enzyme for rna cleavage
12/16/1999WO1999054354A9 Sp22, a fertility-associated protein from sperm and a method for evaluating and affecting male fertility using it
12/16/1999WO1999052947A3 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
12/16/1999WO1999052543A3 Pharmaceutical compositions comprising erythropoietin for treatment of cancer
12/16/1999WO1999049015A3 Cardiac-derived stem cells
12/16/1999WO1999047556A3 Novel heparin-induced ccn-like molecules and uses therefor
12/16/1999WO1999046380A3 Human membrane spanning proteins
12/16/1999WO1999045951A3 Thy-1 expression in angiogenesis
12/16/1999WO1999045107A8 Novel calpain and dna encoding the same
12/16/1999WO1999043807A3 Human channel-related molecules
12/16/1999WO1999043784A3 Novel compositions and methods for enhancing osseous growth, repair and regeneration
12/16/1999WO1999041382A3 A novel interleukin-3 and uses thereof
12/16/1999WO1999041375A3 Human receptor proteins
12/16/1999WO1999041373A3 Human transport-associated molecules
12/16/1999WO1999029865A3 A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof
12/16/1999WO1999006540A3 Inhibitors of cell-cycle progression and uses related thereto
12/16/1999DE19825804A1 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung 1,4-benzothiazepine 1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use
12/16/1999DE19825794A1 Collagenase-Applikationsform Collagenase application form
12/16/1999CA2335007A1 Retinoic acid inducible dna sequences from lung cells
12/16/1999CA2334872A1 Use of exendin-4 to treat impaired glucose tolerance
12/16/1999CA2334812A1 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999CA2334696A1 Purification process for production of mannan-binding lectin and an mbl medicinal product
12/16/1999CA2334551A1 Spiropiperidine derivatives as melanocortin receptor agonists
12/16/1999CA2334338A1 Directed combinatorial compound library and high throughput assays for screening same
12/16/1999CA2334116A1 Treatment of diabetes
12/16/1999CA2333657A1 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
12/16/1999CA2332993A1 Phagocytic assay method
12/16/1999CA2331372A1 Tankyrase, a trfi binding protein
12/16/1999CA2330251A1 Cloning and identification of the motilin receptor
12/16/1999CA2330247A1 Peptide inhibitors of hepatitis c virus ns3 protease
12/16/1999CA2330242A1 Polypeptides with beta-secretase type activity
12/16/1999CA2330240A1 Moraxella catarrhalis pilq proteins
12/16/1999CA2330230A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt)
12/16/1999CA2330229A1 Novel angiotensin receptor, production and use thereof
12/16/1999CA2330211A1 Formulations for electroporation
12/16/1999CA2330168A1 Protein for regulating apoptosis
12/16/1999CA2329947A1 Novel adenoviral vectors for gene therapy
12/16/1999CA2329942A1 Therapeutic and diagnostic domain 1 .beta.2gpi polypeptides and methods of using same
12/16/1999CA2329688A1 Cell cycle regulation proteins
12/16/1999CA2329685A1 Proteins regulating gene expression
12/16/1999CA2328498A1 Monoclonal antibodies, cross-reactive antibodies and method for producing the same____________________________________
12/16/1999CA2321274A1 Novel antiviral compounds
12/16/1999CA2321273A1 Novel analgesic agents
12/16/1999CA2321191A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
12/16/1999CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999CA2321162A1 Novel antibacterial compounds
12/16/1999CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999CA2320241A1 Multivalent macrolide antibiotics
12/16/1999CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999CA2319730A1 Bradykinin antagonists
12/16/1999CA2319651A1 H1-histamine receptor antagonists
12/16/1999CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999CA2319174A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2316999A1 Inhibitors of hiv reverse transcriptase
12/16/1999CA2316994A1 Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs
1 ... 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 ... 3163